Want to see ETON full AI Analyst Report?
Eton Pharmaceuticals (ETON) Income Statement
Eton Pharmaceuticals Income Statement
Last quarter (Q2 2026), Eton Pharmaceuticals's total revenue was $37.59M, an increase of 98.59% from the same quarter last year. In Q2, Eton Pharmaceuticals's net income was $11.58M. See Eton Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 79.95M | $ 39.01M | $ 31.64M | $ 21.25M | $ 21.83M | |
| $ 42.74M | $ 23.41M | $ 21.06M | $ 14.32M | $ 19.21M | |
| $ 42.67M | $ 26.01M | $ 22.25M | $ 22.58M | $ 20.70M | |
| Depreciation and Amortization | $ 4.04M | $ 1.15M | $ 901.00K | $ 1.77M | $ 462.00K |
| $ 4.27M | $ -657.00K | $ 212.00K | $ -7.25M | $ -1.49M | |
| $ 72.00K | $ -2.60M | $ -1.19M | $ -8.26M | $ -1.50M | |
| $ -4.63M | $ -1.21M | $ 503.00K | $ -761.00K | $ -460.00K | |
| $ -4.56M | $ -3.81M | $ -689.00K | $ -9.02M | $ -1.96M | |
| $ -4.60M | $ -3.82M | $ -936.00K | $ -9.02M | $ -1.96M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.17 | $ -0.15 | $ -0.04 | $ -0.36 | $ -0.08 |
| Diluted EPS | $ -0.17 | $ -0.15 | $ -0.04 | $ -0.36 | $ -0.08 |
| Weighted Average Shares Outstanding | 26.91M | 25.89M | 25.64M | 25.15M | 25.21M |
| Weighted Average Shares Outstanding (Diluted) | 26.91M | 25.89M | 25.65M | 25.15M | 25.21M |
Currency in USD